Event Supporters BioTrinity 2013
Media Supporters |
|
|---|---|
 |
PharmaTimes for the independent thinker The PharmaTimes portfolio includes PharmaTimes Magazine for independent reporting; PharmaTimes Online www.pharmatimes.com; three free online e-news services delivered by email including World, UK and Clinical news; PharmaTimes Directors' Club, where thought-leaders meet to discuss the issues of the day; and a unique series of competitions including marketing, clinical, sales and business leadership that help industry professionals develop and hone their skills. PharmaTimes Magazine isn’t just for pharma… in line with the growing recognition that closer working between pharma and healthcare systems is key to 21st century healthcare,PharmaTimes has expanded its focus to provide a platform for both sides to hear about the latest news, thoughts, and initiatives in this important area. |
|
|
|
|
|
Innovations in Pharmaceutical Technology (IPT) Innovations in Pharmaceutical Technology (IPT) magazine offers in-depth comment and analysis written by experts from within the field. IPT covers the latest developments in drug discovery, laboratory technology, formulation, delivery systems, and other insights and innovations in the field. The magazine also presents sector-specific events, company and individual profiles, and reviews. IPT is a platform for those involved in pharmaceuticals and biotechnology to share their ideas with other key industry figures. |
|
|
FreeMind is a consulting group whose goal is to assist its clients in maximizing their potential to receive funding from non-dilutive sources. Established in 1999, FreeMind is the largest consulting group of its kind with over 400 active clients, academics and Industry alike. FreeMind's proven long-term strategic approach has garnered its clients over 1.5 billion dollars to date. Our expertise in applying for grants and contracts extends throughout every government mechanism open to funding the life sciences including all NIH institutes, DoD, NSF, FDA, CDC, BARDA, etc., as well as private foundations such as Michael J Fox, Bill and Melinda Gates and Susan G Komen. FreeMind's knowledgeable and experienced team of Analysts and Project Managers are dedicated to guiding its clients non-dilutive funding efforts from identification of the most suitable opportunity through to submission and subsequent award. Our team of experts will assist our clients in making non-dilutive funding a key tool in their long-term financial strategy. |
|
|
|
|
|
|
|
|
|
|
|
Biopharma Dealmakers From Nature Publishing Group Biopharma Dealmakers, a partnering supplement to Nature Biotechnology and Nature Reviews Drug Discovery, covers the partnering strategies of the industry's movers and shakers, the deals that are shaping our industry, the best emerging biotech and academic innovators, and the contract services that support them. |
|
|
Venture Valuation specializes in independent assessments and valuations of companies in high-growth markets, such as biotechnology, life sciences and medical technology. Furthermore, the company manages and runs the global Biotechgate Database as a subscription service and a white label solution for organizations like BIOTECanada, BioCom San Diego, Swiss Stock Exchange SIX, Swiss Biotech, Biovalley, BioAlps, BIO.NRW, Medicon Valley, SwedenBIO and over 30 partners. The Company Valuation Reports include a thorough assessment of the company by experienced professionals with expertise in the relevant fields. Venture Valuation offers detailed Product Valuation Reports of pre-clinical and clinical products in development that can serve as a basis for negotiations or to structure different deal scenarios. |
|
|
|
|
|
|
Supporters |
|
|---|---|
 |
ASEBIO is the Spanish Bioindustry Association, a private non-profit organization that brings together over 230 companies, foundations, universities and research institutions that undertake their activities either directly or indirectly related to biotechnology in Spain. ASEBIO has been the biotechnology sector platform in Spain since 1999, representing its members' interests before Regional, National and European Governments. ASEBIO is also the BIOSPAIN International Meeting on Biotechnology organizer, a conference that includes a trade exhibition, a partnering event (5th largest worldwide with 2,800 one-to-one meetings in 2012) and an investor forum, among many other activities. |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Biowales and Welsh Govt. |
|
|
|
|
|
|
|
|
|
|
|
Sherbrooke International Life Sciences Summit, September 26th and 27th 2013, is a not-to-be-missed event for an overview of the Life Sciences industry and to identify development perspectives. Organized by Sherbrooke Innopole in partnership with Rx&D and MEDEC, this world-class event brings together participants from the pharmaceutical and medical technologies industries – large and small businesses – and investors, as well as representatives from governments, universities, and the economic development sector so they can work together at building opportunities. On the menu: conferences, panels, B2B meetings, an innovative showcase, and more! In Sherbrooke, Québec CANADA www.sils-sherbrooke.com |
If you are a trade body and are interested in becoming a supporter of BioTrinity, please contact Amanda Taylor on +44 (0) 845 521 5222 or amanda.taylor@obn.org.uk
| BioTrinity 2012 highlights |
|---|
| 800 delegates from 26 countries |
| 500 companies |
| 130 speakers |
| 75 company presentations |
| 1850 scheduled one-to-one meetings |
| 80 investors from 10 countries |
| 69 exhibitors |
| 22 global pharma |
